Welcome to our annual celebration of the great and inspirational minds that contribute to the development and manufacture of new medicinal products
The complexity and scope of tasks within (bio)pharma lends itself to outsourcing, but finding the right partner can be daunting.
When it comes to developing cell and gene therapies, you need to keep your eye on the end goal of commercial manufacturing.
Samsung Biologics give their opinion on working with the M Lab™ Collaboration Centers.
Welcome to the M Lab™ Collaboration Centers – where customers can use non-GMP lab spaces to operate equipment, evaluate processes and receive...
Chin Bin Tan
Enter a space where you can explore new ideas, learn innovative techniques, and work side by side with technical experts
Nominations are now open for The Medicine Maker 2020 Power List.
A new publication will give the small molecule manufacturing community the attention and praise it deserves. Meet The Small Molecule Manufacturer.
ADCs have suffered a few setbacks over the years, but interest in their therapeutic potential – particularly against cancer – remains high.
Sitting Down With… Jinling Chen, Vice President, Pharmaceutical Development Services, WuXi STA, China.
Blockchain could be one solution to the saleable returns verification aspect of the US’ Drug Supply Chain Security Act.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.